The promise and reality of cancer gene therapy

被引：8

作者：

Hall, SJ

Chen, SH

Woo, SLC

机构：

[1] MT SINAI SCH MED,INST GENE THERAPY & MOL MED,NEW YORK,NY 10029

[2] MT SINAI SCH MED,DEPT UROL,NEW YORK,NY 10029

[3] MT SINAI SCH MED,DEPT HUMAN GENET,NEW YORK,NY 10029

来源：

AMERICAN JOURNAL OF HUMAN GENETICS | 1997年 / 61卷 / 04期

关键词：

D O I：

10.1086/514898

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

[No abstract available]

引用

收藏

页码：785 / 789

页数：5

相关论文

共 58 条

[31] HENDRZAK JA, 1995, LAB INVEST, V72, P619
[32] HUBER BE, 1993, CANCER RES, V53, P4619
[33] Kanai F, 1997, CANCER RES, V57, P461
[34] Khil MS, 1996, CLIN CANCER RES, V2, P53
[35] SELECTIVE ENHANCEMENT OF RADIATION RESPONSE OF HERPES-SIMPLEX VIRUS THYMIDINE KINASE TRANSDUCED 9L GLIOSARCOMA CELLS IN-VITRO AND IN-VIVO BY ANTIVIRAL AGENTS
KIM, JH
KIM, SH
KOLOZSVARY, A
BROWN, SL
KIM, OB
FREYTAG, SO
[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 33 (04): : 861 - 868
[36] SYSTEMIC GENE-THERAPY WITH P53 REDUCES GROWTH AND METASTASES OF A MALIGNANT HUMAN BREAST-CANCER IN NUDE-MICE
LESOONWOOD, LA
KIM, WH
KLEINMAN, HK
WEINTRAUB, BD
MIXSON, AJ
[J]. HUMAN GENE THERAPY, 1995, 6 (04) : 395 - 405
[37] LINSLEY PS, 1993, ANNU REV IMMUNOL, V11, P199
[38] P53 STATUS AND THE EFFICACY OF CANCER-THERAPY IN-VIVO
LOWE, SW
BODIS, S
MCCLATCHEY, A
REMINGTON, L
RULEY, HE
FISHER, DE
HOUSMAN, DE
JACKS, T
[J]. SCIENCE, 1994, 266 (5186) : 807 - 810
[39] Bystander killing of cancer cells by herpes simplex virus thymidine kinase gene is mediated by connexins
Mesnil, M
Piccoli, C
Tiraby, G
Willecke, K
Yamasaki, H
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (05) : 1831 - 1835
[40] MOOLTEN FL, 1986, CANCER RES, V46, P5276

← 1 2 3 4 5 6 →